Other functions -custome monoclonal antibody production

Ended Purchase Order Awarded Last action

Contract number
HHSN275201500217P
Awardee
Awarding agency
Obligated
$10,122

Award facts

Contract value 100% obligated
$10,121.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 · Custome monoclonal antibody production -$296
Original award $10,418

About this award

This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Abpro Corporation on May 18, 2015 for the production of custom monoclonal antibodies. The contract has a ceiling value of $10,121.80 and an ultimate completion date of May 20, 2020. The contract was not set aside for any specific business type. Abpro Corporation is a minority-owned, for-profit business that manufactures goods. This contract award is not associated with a larger vehicle.

Quick answers

Who was awarded contract HHSN275201500217P?

HHSN275201500217P was awarded to Abpro Corporation by National Institute of Child Health and Human Development (National Institutes of Health) on May 18, 2015.

How much is contract HHSN275201500217P worth?

The government has obligated $10,122 on HHSN275201500217P.

Was contract HHSN275201500217P competed?

The extent of competition for HHSN275201500217P was competed under sap. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award